| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681551 | Brain Stimulation | 2018 | 31 Pages |
Abstract
For DMPFC-rTMS, a '<20% improvement at 2 weeks' rule concurred with previous pharmacotherapy and ECT studies on predicting nonresponse, and could prove useful for treatment decision-making in clinical settings.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Kfir Feffer, Hyewon Helen Lee, Farrokh Mansouri, Peter Giacobbe, Fidel Vila-Rodriguez, Sidney H. Kennedy, Zafiris J. Daskalakis, Daniel M. Blumberger, Jonathan Downar,